You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clostridium difficile

Showing 76 - 100 of 2,514
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clostridium Difficile Infection Trial in Canada, United States (RBX2660, Placebo)

Completed
  • Clostridium Difficile Infection
  • Athens, Alabama
  • +65 more
Jul 29, 2022

Clostridium Difficile Infection Trial in Canada, United States (Comparison between GenePOC PCR and Reference Method)

Completed
Has Results
  • Clostridium Difficile Infection
  • Comparison between GenePOC PCR and Reference Method
  • Indianapolis, Indiana
  • +6 more
Apr 29, 2021

Clostridium Difficile Infection Recurrence Trial in Spain (MBK-01, Dificlir)

Recruiting
  • Clostridium Difficile Infection Recurrence
  • Santander, Cantabria, Spain
  • +20 more
Jun 13, 2022

Clostridioides Difficile Infection Trial in Madrid (Oral Vancomycin, Placebo)

Recruiting
  • Clostridioides Difficile Infection
  • Oral Vancomycin
  • Placebo
  • Madrid, Spain
    Unidad de Enfermedades Infecciosas. Hospital Universitario 12 de
Aug 2, 2022

Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection, Clostridium Difficile Trial in Canada, United

Completed
  • Clostridium Difficile Infection Recurrence
  • +3 more
  • Phoenix, Arizona
  • +36 more
Sep 28, 2021

Clostridium Difficile Trial in United States (Fecal Microbiota Preparation)

Terminated
Has Results
  • Clostridium Difficile
  • Fecal Microbiota Preparation
  • Naperville, Illinois
  • +3 more
Feb 5, 2021

Clostridium Difficile Infection Trial in Rochester (RBX7455)

Completed
  • Clostridium Difficile Infection
  • RBX7455
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 7, 2020

Clostridium Difficile Infection, Health Care Associated Infection, Nosocomial Infection Trial in Spain

Recruiting
  • Clostridium Difficile Infection
  • +2 more
    • Orihuela, Alicante, Spain
    • +14 more
    Nov 3, 2021

    Clostridium Difficile Infection Trial in Reno (Oral Vancomycin)

    Unknown status
    • Clostridium Difficile Infection
    • Oral Vancomycin
    • Reno, Nevada
      Renown Regional Medical Center
    Dec 9, 2020

    Clostridioides Difficile Infection Trial in Turku (FMT, enema)

    Recruiting
    • Clostridioides Difficile Infection
    • FMT
    • placebo enema
    • Turku, Finland
      Turku University hospital
    Feb 17, 2022

    Clostridium Difficile Infection Trial in United States (Ibezapolstat, Vancomycin)

    Recruiting
    • Clostridium Difficile Infection
    • Scottsdale, Arizona
    • +28 more
    Jan 31, 2023

    Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome Trial in Greece (Bezlotoxumab, Normal saline

    Recruiting
    • Clostridioides Difficile Infection
    • +4 more
    • Alexandroupoli, Greece
    • +15 more
    May 11, 2022

    Diarrhea, Clostridium Difficile Trial in Beirut (Probiolife by Green Made (Pharma M), Placebo)

    Terminated
    • Diarrhea, Clostridium Difficile
    • Probiolife by Green Made (Pharma M)
    • Placebo
    • Beirut, Lebanon
      Saint Joseph University of Beirut
    Oct 22, 2020

    Clostridium Difficile Trial (PRIM-DJ2727)

    Withdrawn
    • Clostridium Difficile
    • (no location specified)
    Jan 25, 2021

    Clostridioides Difficile Infection Trial (SER-109)

    Available
    • Clostridioides Difficile Infection
    • SER-109
    • (no location specified)
    Nov 23, 2021

    Clostridium Difficile Associated Disease Trial in United States (Clostridium difficile Vaccine, Placebo)

    Completed
    Has Results
    • Clostridium Difficile Associated Disease
    • Clostridium difficile Vaccine
    • Placebo
    • DeLand, Florida
    • +16 more
    Feb 11, 2021

    Clostridium Difficile Infections in Hospitalized Patients on

    Completed
    • Clostridium Difficile
    • no intervention
    • La Roche-sur-Yon, France
    • +33 more
    May 18, 2021

    Clostridium Difficile Infection Trial in Canada, United States (RBX2660, Standard of Care Antibiotics)

    Completed
    Has Results
    • Clostridium Difficile Infection
    • RBX2660
    • Standard of Care Antibiotics
    • Phoenix, Arizona
    • +29 more
    Mar 25, 2021

    Clostridium Difficile Infection Trial in Worldwide (VP20621, Placebo)

    Completed
    Has Results
    • Clostridium Difficile Infection
    • VP20621
    • Placebo
    • Modesto, California
    • +58 more
    May 30, 2021

    Mucosal Microbiome After Treatment of Clostridioides Difficile

    Recruiting
    • Clostridioides Difficile Infection
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Oct 5, 2021

      Crohn Disease, Ulcerative Colitis, Celiac Disease Trial in Hong Kong (Fecal Microbiota Transplantation)

      Recruiting
      • Crohn Disease
      • +26 more
      • Fecal Microbiota Transplantation
      • Hong Kong, Shatin, Hong Kong
        The Chinese University of Hong Kong
      Feb 10, 2022

      Clostridium Difficile Infection Recurrence Trial in Canada, United States (Full Spectrum Microbiota, Placebo)

      Completed
      Has Results
      • Clostridium Difficile Infection Recurrence
      • Full Spectrum Microbiota
      • Placebo
      • Scottsdale, Arizona
      • +57 more
      Jun 10, 2022

      Clostridium, Difficile, Fidaxomicin Trial in Puerto Rico, United States (Fidaxomicin, Vancomycin with Taper/Pulse, Vancomycin)

      Recruiting
      • Clostridium
      • +3 more
      • Phoenix, Arizona
      • +32 more
      Jan 4, 2022

      Clostridium Difficile Infection Trial in Norway (Intestinal microbiota therapy, Metronidazole)

      Terminated
      • Clostridium Difficile Infection
      • Sandvika, Gjettum, Norway
      • +6 more
      Sep 18, 2020

      Clostridium Difficile Infection, C.Difficile Diarrhea, CDI Trial in Madison (Low Dose FMT Capsule DE, Single Dose FMT Capsule

      Completed
      Has Results
      • Clostridium Difficile Infection
      • +2 more
      • Low Dose FMT Capsule DE
      • +2 more
      • Madison, Wisconsin
        University of Wisconsin Hospital & Clinics
      Feb 19, 2021